Literature DB >> 3496934

Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs.

A J Collins, J A Du Toit.   

Abstract

An upper gastrointestinal endoscopic examination was performed, following a test for faecal occult blood, on a group of 108 patients with rheumatic complaints. The majority of the group studied had rheumatoid arthritis (RA) and 50% of the total group were anaemic. Every patient was taking a single nonsteroidal anti-inflammatory drug (NSAID). When the finding of blood in the faeces was compared with findings in the upper gastrointestinal tract, approximately half the subjects with ulcerative and inflammatory lesions had a positive test for blood. However, 50% of the subjects with an apparently normal upper gastrointestinal tract had a positive test for blood in the stool and these comprised the largest group of those examined. It was concluded that the finding of a positive faecal occult blood in such subjects is a poor indicator of ulcerative or inflammatory lesions of the upper gastrointestinal tract. The possible reasons for a finding of blood in the stool of patients taking NSAID who apparently have a normal upper gastrointestinal tract is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496934     DOI: 10.1093/rheumatology/26.4.295

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  16 in total

Review 1.  Non-steroidal anti-inflammatory drugs and peptic ulcers.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1990-02-03

Review 2.  Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors:  S Szabo; W F Spill; K D Rainsford
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

3.  Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration.

Authors:  S M Kelly; J Crampton; J O Hunter
Journal:  BMJ       Date:  1990-09-01

Review 4.  Drug toxicity.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1990-05       Impact factor: 19.103

5.  Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism.

Authors:  A Z Leite; A M Sipahi; A O Damião; A M Coelho; A T Garcez; M C Machado; C A Buchpiguel; F P Lopasso; M L Lordello; C L Agostinho; A A Laudanna
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 6.  Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: to be considered in certain circumstances.

Authors:  M Doherty
Journal:  BMJ       Date:  1989-01-21

7.  Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.

Authors:  B Cardario; A A McKinnon
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

8.  Interobserver variation in assessment of gastroduodenal lesions associated with non-steroidal anti-inflammatory drugs.

Authors:  N Hudson; S Everitt; C J Hawkey
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

9.  High prevalence of NSAID enteropathy as shown by a simple faecal test.

Authors:  J A Tibble; G Sigthorsson; R Foster; D Scott; M K Fagerhol; A Roseth; I Bjarnason
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

10.  Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis.

Authors:  A B Hawthorne; Y R Mahida; A T Cole; C J Hawkey
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.